gRNA Market to Grow with a CAGR of 18.54% through 2029
Rising development in bioprocessing is expected to drive the Global gRNA Market in the forecast period 2025-2029
According
to TechSci Research report, “gRNA Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029F”, the Global
gRNA Market stood at USD 498.23 million in 2023 and is
anticipated to grow with a CAGR of 18.54% in the forecast period through 2029. The
gRNA market is thriving within the realm of genetic engineering and genome
editing, propelled by rapid advancements in biotechnology and molecular
biology. As demand surges for precise and efficient genome editing tools, gRNA
stands at the forefront of this evolution, being a crucial component of CRISPR
technology. CRISPR, or Clustered Regularly Interspaced Short Palindromic
Repeats, enables targeted modifications of genes across diverse sectors
including agriculture, healthcare, and research. In agriculture, gRNA's
integration into CRISPR-based genome editing has the potential to revolutionize
crop enhancement by improving traits such as yield, disease resistance, and
nutritional value. Similarly, the healthcare sector is witnessing a surge in
gRNA technology adoption for therapeutic applications, particularly in
developing treatments for genetic disorders and various cancers. The
adaptability of gRNA allows precise targeting and modification of specific
genes, paving the way for personalized medicine tailored to individual genetic
profiles. The gRNA market is characterized by a dynamic landscape driven by
ongoing research and development efforts to enhance CRISPR technology's
precision and efficiency. Collaborative ventures between biotechnology firms,
academic institutions, and research organizations are fostering innovation and
expanding the capabilities of genome editing tools. Consequently, the gRNA
market is poised for sustained growth in the coming years.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global gRNA Market”
Global gRNA Market is segmented into type, Proucts & Services, application,
end use, regional distribution, and company.
Based on Application, the market is divided
into Genome Engineering, Disease Model Studies, Functional Genomics,
Epigenetics, and Others. Genome Engineering dominated the market in 2023.This is
ascribed due to its transformative impact on genetic modifications. The ability
to precisely edit DNA sequences using technologies like CRISPR-Cas systems
empowers scientists to modify genes with unprecedented accuracy. This precision
is vital for applications ranging from therapeutic interventions and
personalized medicine to crop improvement in agriculture. Genome engineering's
versatility, efficiency, and broad applicability across various sectors
contribute to its dominance, revolutionizing how we approach genetic
manipulation for diverse purposes.
Based on region, North America led the global gRNA market in 2023, largely due to the significant presence of major industry players in the region. This local concentration of key companies boosts overall market growth. The region is seeing increased research and development investments by these leading firms, aimed at creating innovative and advanced gRNA products. The collaborative efforts of industry leaders, along with heightened R&D spending, have positioned North America at the forefront of the global gRNA market.
Major companies operating in Global gRNA Market are:
·
Thermo Fisher Scientific, Inc.
·
Agilent Technologies, Inc.
·
System Biosciences, LLC
·
Jena Bioscience GmbH
·
Merck KGaA
·
Azenta US, Inc.
·
Takara Bio, Inc.
·
Synbio Technologies
·
Revvity, Inc.
·
Synthego Corporation
Download Free Sample Report
Customers can also request for 10% free customization on
this report
“The
gRNA market is propelled by escalating demand for precise genome editing tools
in biotechnology and healthcare. As CRISPR technology gains prominence, the
versatility of gRNA in targeted gene modification enhances its significance. In
agriculture, gRNA's potential for crop improvement amplifies its market demand.
Ongoing research and development endeavors, coupled with strategic
collaborations, drive innovation and expand the applications of gRNA. The quest
for efficient and customizable genome editing tools, combined with the
transformative impact of gRNA in therapeutic interventions and genetic
research, positions it as a pivotal driver in the rapidly evolving landscape of
genetic engineering”, said Mr. Karan Chechi, Research Director of TechSci Research,
a research-based management consulting firm.
“gRNA Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Research-Use, GMP-grade), By Product & Services (Product (gRNA Final Products, gRNA Synthesis Products (gRNA Synthesis Kits, Plasmids, Others)), Custom gRNA Synthesis Services), By Application (Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics, Others), By End-Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CMOs & CROs), By Region and Competition, 2019-2029F”, has evaluated the
future growth potential of Global gRNA Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global gRNA Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com